NEW YORK, Aug. 3, 2023 /PRNewswire/ -- The pre-filled syringes market is to grow by USD 3,512.4 million from 2022 to 2027 progressing at a CAGR of 8.93% during the forecast period. Discover Health Care Supplies industry potential and make informed business decisions based on qualitative and quantitative evidence highlighted in Technavio reports. View Sample Report!
The pre-filled syringes market covers the following areas:
Pre-filled Syringes Market Sizing
Pre-filled Syringes Market Forecast
Pre-filled Syringes Market Analysis
The pre-filled syringes market is fragmented, and the vendors are deploying organic and inorganic growth strategies to compete in the market.
ApiJect Systems Corp. - The company offers prefilled syringes such as Prefilled ApiJect Injector is the combination of two trusted technologies, the Blow Fill Seal aseptic drug packaging process, and a pen needle style needle hub.
Baxter International Inc. - The company offers prefilled syringes such as clinical through high-volume commercial sterile manufacturing.
Fresenius SE and Co. KGaA - The company offers prefilled syringes such as Glycopyrrolate.
For the market's vendor landscape highlights with a comprehensive list of vendors and their offerings - View Sample in a minutes
Key Market Segmentation
The market is segmented by material (glass pre-filled syringes and plastic pre-filled syringes), and type (disposable and reusable).
The market share growth by the glass pre-filled syringes segment will be significant during the forecast period. Glass-filled syringes are preferred for parenteral drugs because it is non-reactive and stable during storage and is permeable to oxygen, which can be a major problem for oxygen-sensitive drugs such as morphine. In addition, wider end-user acceptability and a larger number of drugs are available in glass-prefilled syringes compared to plastic-prefilled syringes.
View Sample Report in minutes of this report for more highlights into the market segments.
Regional Market Outlook
By geography, the market is segmented by North America, Europe, Asia, and the Rest of the World (ROW).
North America is estimated to contribute 36% to the growth of the global market during the forecast period. This is due to the increasing incidence of chronic diseases, such as diabetes and vaccine-preventable infectious diseases. The technological advancements in prefilled syringes and Centers for Disease Control and Prevention (CDC) recommendations are other factors influencing the growth of the prefilled syringe market in the region. Additionally, healthcare reform in the United States is aimed at reducing end-user healthcare costs. Hence, these factors are expected to drive market growth in the region during the forecast period.
For more key highlights on the regional market share of most of the above-mentioned countries.- View Sample Report
Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
Global competitiveness and key competitor positions
Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - buy the report!
Ajinomoto Bio-Pharma Services
ApiJect Systems Corp.
Baxter International Inc.
Becton Dickinson and Co.
Fresenius SE and Co. KGaA
Owen Mumford Ltd.
SHL Medical AG
Vetter Pharma Fertigung GmbH and Co. KG
West Pharmaceutical Services Inc.
The shift from glass pre-filled syringes to plastic pre-filled syringes is a key factor driving market growth. This is due to the introduction of advanced polymeric materials such as polypropylene and clear polymers, clear polymer resin prefilled syringes are becoming increasingly popular, and biocompatible with other syringe components. Because of the inherent disadvantages of glass prefilled syringes, such as their tendency to break and drug interactions, over time, manufacturers have turned to plastic as the preferred material for prefilled syringes. Furthermore, advances in polymer technology have further increased the use of plastic pre-filled syringes. Hence, these factors are expected to drive market growth during the forecast period.
Innovations in pre-filled syringes is a major trend in the market. Many vendors are offering built-in automatic needle shields and retractable needle syringes. Furthermore, some specialized pre-filled syringe manufacturers have developed dual syringes and multiple compartments for lyophilization. For example, Pfizer (XYNTHA) and Takeda Pharmaceutical Company (Prolia) have begun to package lyophilized drugs in dual/multi-compartment syringes. Hence, these advancements in innovations are expected to drive market growth during the forecast period.
The limitations and drawbacks of the devices are one of the significant challenges restricting market growth. The quality of the drug can be affected when stored in a pre-filled syringe because the drug is in direct contact with the main packaging of the syringe for a long time. In addition, tungsten residues in prefilled syringes can also degrade biotech drugs. There have been many cases where pharmaceutical companies supplying drugs in pre-filled syringes had to recall their products due to drug interactions. Thus, these factors are expected to restrict market growth during the forecast period.
Gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Related Reports:The catheter market is estimated to grow at a CAGR of 7.86% between 2022 and 2027. The market size is forecast to increase by USD 16,348.19 million. Furthermore, this report extensively covers market segmentation by distribution channel (hospital stores, retail stores, and others), product type (cardiovascular catheters, specialty catheters, intravenous catheters, urinary catheters, and neurovascular catheters), and geography (North America, Europe, Asia, and Rest of World (ROW)). The technological advancements in catheter industries is a key factor driving market growth during the forecast period.
The hemostats and tissue sealants market is estimated to grow by USD 2,558.35 million at a CAGR of 10.18% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by product (hemostats, tissue sealants and adhesives, and fibrin sealants), end-user (hospitals, ambulatory surgical centers, homecare settings, and others), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The growth of oncology tourism is a major trend in the market.
Pre-filled Syringes Market Scope
Growth momentum & CAGR
Accelerate at a CAGR of 8.93%
Market growth 2023-2027
USD 3,512.4 million
YoY growth 2022-2023(%)
North America, Europe, Asia, and the Rest of the World (ROW)
Performing market contribution
North America at 36%
US, Canada, Germany, UK, and China
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled
Ajinomoto Bio Pharma Services, ApiJect Systems Corp., AptarGroup Inc., Baxter International Inc., Becton Dickinson and Co., Catalent Inc., Fresenius SE and Co. KGaA, Gerresheimer AG, Haselmeier GmbH, Nipro Corp., Novartis AG, Owen Mumford Ltd., Recipharm AB, SCHOTT AG, SHL Medical AG, STERINOVA, Terumo Corp., Vetter Pharma Fertigung GmbH and Co. KG, Viatris Inc., and West Pharmaceutical Services Inc.
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Table of Contents
1 Executive Summary
1.1 Market Overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
4 Historic Market Size
4.1 Global pre-filled syringes market 2017 - 2021
4.2 Material Segment Analysis 2017 - 2021
4.3 Type Segment Analysis 2017 - 2021
4.4 Geography Segment Analysis 2017 - 2021
4.5 Country Segment Analysis 2017 - 2021
5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition
6 Market Segmentation by Material
6.1 Market segments
6.2 Comparison by Material
6.3 Glass pre-filled syringes - Market size and forecast 2022-2027
6.4 Plastic pre-filled syringes - Market size and forecast 2022-2027
6.5 Market opportunity by Material
7 Market Segmentation by Type
7.1 Market segments
7.2 Comparison by Type
7.3 Disposable - Market size and forecast 2022-2027
7.4 Reusable - Market size and forecast 2022-2027
7.5 Market opportunity by Type
8 Customer Landscape
8.1 Customer landscape overview
9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2022-2027
9.4 Europe - Market size and forecast 2022-2027
9.5 Asia - Market size and forecast 2022-2027
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
9.7 US - Market size and forecast 2022-2027
9.8 Canada - Market size and forecast 2022-2027
9.9 Germany - Market size and forecast 2022-2027
9.10 China - Market size and forecast 2022-2027
9.11 UK - Market size and forecast 2022-2027
9.12 Market opportunity by geography
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends
11 Vendor Landscape
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks
12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 ApiJect Systems Corp.
12.4 AptarGroup Inc.
12.5 Baxter International Inc.
12.6 Becton Dickinson and Co.
12.7 Catalent Inc.
12.8 Fresenius SE and Co. KGaA
12.9 Gerresheimer AG
12.10 Haselmeier GmbH
12.11 Nipro Corp.
12.12 Novartis AG
12.13 Owen Mumford Ltd.
12.14 Recipharm AB
12.15 SCHOTT AG
12.16 Terumo Corp.
12.17 Viatris Inc.
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
ContactTechnavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: [email protected]: www.technavio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-pre-filled-syringes-market-size-to-grow-at-a-cagr-of-8-93-from-2022-to-2027the-shift-from-glass-pre-filled-syringes-to-plastic-pre-filled-syringes-to-boost-market-growth---technavio-301891423.html